- Home
- DRUG vs PWOD Comparison
DRUG vs PWOD Comparison
Compare DRUG & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- PWOD
- Stock Information
- Founded
- DRUG 2019
- PWOD 1934
- Country
- DRUG United States
- PWOD United States
- Employees
- DRUG N/A
- PWOD N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- PWOD Major Banks
- Sector
- DRUG Health Care
- PWOD Finance
- Exchange
- DRUG Nasdaq
- PWOD Nasdaq
- Market Cap
- DRUG 199.7M
- PWOD 231.2M
- IPO Year
- DRUG N/A
- PWOD N/A
- Fundamental
- Price
- DRUG $33.63
- PWOD N/A
- Analyst Decision
- DRUG Strong Buy
- PWOD
- Analyst Count
- DRUG 7
- PWOD 0
- Target Price
- DRUG $83.25
- PWOD N/A
- AVG Volume (30 Days)
- DRUG 37.4K
- PWOD 78.2K
- Earning Date
- DRUG 08-13-2025
- PWOD 08-08-2025
- Dividend Yield
- DRUG N/A
- PWOD 4.27%
- EPS Growth
- DRUG N/A
- PWOD 28.19
- EPS
- DRUG N/A
- PWOD 2.80
- Revenue
- DRUG N/A
- PWOD $74,314,000.00
- Revenue This Year
- DRUG N/A
- PWOD N/A
- Revenue Next Year
- DRUG N/A
- PWOD N/A
- P/E Ratio
- DRUG N/A
- PWOD $10.73
- Revenue Growth
- DRUG N/A
- PWOD 16.68
- 52 Week Low
- DRUG $0.94
- PWOD $20.18
- 52 Week High
- DRUG $79.02
- PWOD $34.56
- Technical
- Relative Strength Index (RSI)
- DRUG 64.40
- PWOD 5.25
- Support Level
- DRUG $31.80
- PWOD $29.91
- Resistance Level
- DRUG $36.50
- PWOD $32.20
- Average True Range (ATR)
- DRUG 2.44
- PWOD 0.51
- MACD
- DRUG 0.79
- PWOD -3.82
- Stochastic Oscillator
- DRUG 70.86
- PWOD 0.00
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About PWOD Penns Woods Bancorp Inc.
Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.